GSK transforms to improve pharmaceutical operationsStaff writerGlaxoSmithKline (GSK) in July made its consumer health products division a separate entity as it transforms into a world-leading biopharmaceutical company. Mick Stanley, VP and General Manager of GSK Taiwan, says,"after transforming the organization our new ambitions and new purpose is to expand our impact here in Taiwan." For example, GSK Taiwan has recently launched a new vaccine against the herpes zoster virus to protect against shingles. In addition to vaccines, GSK also leads the industry in the treatment and prevention of diseases such as respiratory illnesses. For people with asthma, chronic obstructive pulmonary disease and other respiratory diseases who need drugs for treatment, GSK helps them with a variety of inhaled medicines.
